However, this finding was different from a few studies, which found that APPL1 was highly expressed in cholangiocarcinoma (CHOL), liver hepatocellular carcinoma (LIHC), stomach adenocarcinoma (STAD), and breast cancer. Here, APPL1 is linked to breast cancer.